Pfizer Inc (NYSE:PFE) had its price target trimmed by Jefferies Group to $36.00 in a research note issued to investors on Monday, AnalystRatingsNetwork reports. The firm currently has a buy rating on the stock. Pfizer Inc. (NYSE:PFE) shares after opening at $29.97 moved to $30.15 on last trade day and at the end of the day closed at $29.89. Company price to sales ratio in past twelve months was calculated as 3.70 and price to cash ratio as 5.90. Pfizer Inc. (NYSE:PFE) showed a negative weekly performance of -3.17%.
ARIAD Pharmaceuticals, Inc (NASDAQ:ARIA) announced that it has initiated a phase II pivotal study that will evaluate the safety and efficacy of AP26113 in locally advanced or metastatic non-small cell lung cancer (:NSCLC) in patients who had previously been treated withPfizer’s (PFE) Xalkori (crizotinib). Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares fell -4.70% in last trading session and ended the day on $6.69. ARIA return on equity ratio is recorded as -98.50% and its return on assets is -65.80%. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) yearly performance is -62.48%.
Inovio Pharmaceuticals Inc (NYSE:INO) CEO Jong Joseph Kim bought 25,000 shares of the company’s stock in a transaction dated Tuesday, April 15th. Inovio Pharmaceuticals Inc (NYSEMKT:INO) shares moved down -2.62% in last trading session and was closed at $2.60 while trading in range of $2.13 – $2.66 – Inovio Pharmaceuticals Inc (NYSEMKT:INO)year to date (YTD) performance is -10.34%.
Johnson & Johnson (NYSE:JNJ) reported very strong first-quarter earnings in the pre-market, which helped US equities rally strongly in early trading. Johnson & Johnson (NYSE:JNJ) weekly performance is 1.16%. On last trading day company shares ended up $99.20. Johnson & Johnson (NYSE:JNJ) distance from 50-day simple moving average (SMA50) is 5.99%. Analysts mean target price for the company is $101.08.
Leave a Reply